apotex-latam-25th-anniversary-2021
News Article
Canadian Apotex, a pioneer in the Mexican generics market, celebrates 25 years of work in Latin America.
Was the COVID-19 Pandemic Preventable? WHO Explains
Weekly Roundups
This week WHO discussed how the current pandemic could have been avoided, while real-time solutions move forward
IMG_2017_Americo García_01
View from the Top
Américo García
Director General of Mexico and Latin America
Apotex
Américo García, Director General of Mexico and Latin America at Apotex, discusses new trends and challenges in the pharma industry.
Nitrosamine, the Industry’s Silent Growing Concern
News Article
COVID-19 is not the only concern for the health industry. Learn about the potential threat nitrosamine poses to the pharma market.
AMÉRICO GARCÍA Director General of Mexico and Latin America at Apotex
View from the Top
Américo García
Director General of Mexico and Latin America
Apotex
A quick response and high adaptability are vital during the pandemic. How has Apotex reacted to the crisis?
Generics
Roundtable
Gurulinga Konanur
Gurulinga Konanur
Director General of Hetero Mexico

There are few API manufacturers in Mexico. As a result, we hold strong ground in Mexico. The quality of a medication relies entirely on the quality of the API. Developing an API requires significantly more investment in R&D than in manufacturing of the finished product. We invest heavily in R&D and we often begin planning them over 10 years before they go off patent. This helps us to offer products to clients at a much more advanced or early stage of product development. We see the biggest competition coming from Asian companies that offer their products at a low price, but they lack great services and speed to reach the market. Hetero has a 500ha chemical complex in Vizag, India that manufactures 24/7, which allows us to offer a high volume of high-quality products at affordable costs.

Stronger regulations on generics production, along with high costs of patent medications, have led to a boom in the Mexican generics market
Analysis chart Generics
Analysis
Generics are always an attractive alternative for those who need medication at accessible prices, be they individuals or healthcare systems.
Americo Garcia
View from the Top
Américo García
Director General
Mexico and Latin America at Apotex
Apotex manufactures and commercializes generic and innovative drugs in more than 115 countries.
Américo García
View from the Top
Américo García
Director General of Mexico and Latin America
Apotex
Apotex is a pharmaceutical company, with over 10,000 people employed worldwide in its research, development, manufacturing and distribution facilities
Subscribe to Apotex